ABOUT CARDIOVASCULAR JOURNAL OF AFRICA
The Cardiovascular Journal of Africa (CVJA) is an international peer-reviewed journal that keeps cardiologists up to date with advances in the diagnosis and treatment of cardiovascular disease.

Topics covered include coronary disease, electrophysiology, valve disease, imaging techniques, congenital heart disease (fetal, paediatric & adult), heart failure, surgery, & basic science. CVJA is the official journal of the PASCAR and has been published since 1990.
LATEST JOURNALS
Cardiovascular Journal of Africa: Volume 25, Issue 2, March / April 2014

• Comparison of left ventricular ejection fractions
• Infective endocarditis and HIV
• Neonatal arrhythmias
• Behcet’s disease and cardiovascular involvement
• Topical hypothermia in CABG surgery
• Intra-uterine growth restriction and hypertension
• Impact of prehypertension in adult black Nigerians
• Optimal utilisation of sulphonylureas
• Perforation during radiofrequency catheter ablation

This journal is now available to be viewed via our eJournal publication viewer »
cardiovascular disease
Cardiovascular Journal of Africa: Volume 25, Issue 1, January / February 2014

• Multiple thrombophilic gene profiles in coronary slow flow
• Atrial electromechanical coupling intervals in pregnancy
• Real-world cost-effectiveness of TAVI
• Metabolic syndrome and optimal cut-off values in Angola
• Echocardiography of LV filling pressures with mitral valve stenosis
• Chronic dissecting aneurysm of the ascending aorta
• PCI in a centenarian patient with acute MI

This journal is now available to be viewed via our eJournal publication viewer »
LATEST NEWS & REVIEWS
15th Annual SA Heart Congress

SA Heart Congress 2014 will be held in Durban, from 16 - 19 October, with the central theme being 'Bridging the Divide'. This is the divide that exists between current best practice - and the challenges encountered in implementing these ideals. All medical and allied professionals with an interest in cardiac health are warmly invited by the organising committee to attend.

Congress Information available at www.saheartcongress2014.co.za »
cardiovascular disease
Drug Trends in Cardiology: Cryoballoon ablation for atrial fibrillation is now possible in
South Africa


Dr Razeen Gopal, head of the Mediclinic Panorama electrophysiology laboratory, recently discussed various successful procedures performed in their cardiac unit over the past three years that have radically changed the lifestyle of patients with serious cardiac conditions. ‘Over 1 000 people, including children, have benefitted from the advances in complex ablation procedures as the unit has become established as a centre of excellence, keeping pace with what is happening in
the rest of the world’, he said.

Read full article free online »
cardiovascular disease
Bayer’s Xarelto® is approved in South Africa across five additional indications

Xarelto 15 and 20 for the prevention of stroke in patients with non-valvular atrial fibrillation, treatment of deep-vein thrombosis and pulmonary embolism, and the prevention of recurrent deep-vein thrombosis and pulmonary embolism.

Read full article free online »
cardiovascular disease
Industry News: AstraZeneca Pharmaceuticals enables scientific innovation

Critically aware of the need for funding that will develop research capacity and contribute to academic advancement in South Africa, ethical pharmaceutical company, AstraZeneca Pharmaceuticals, has set up a not-for-profit trust for the disbursement of medical research funding. The company will award R1.5 million a year for three years for academic research; high-level, non-interventional studies including doctoral and postdoctoral work that will generate significant data currently not available.

Read full article free online »
cardiovascular disease
The ADVANCE cardiovascular risk model and current strategies for cardiovascular disease risk evaluation in people with diabetes

Purpose: To critically examine existing approaches to cardiovascular disease (CVD) risk evaluation in people with diabetes, and discuss the use of accurate and validated absolute CVD risk tools as an appropriate basis for CVD prevention in people with diabetes.

Read full article free online: dx.doi.org/10.5830/CVJA-2013-078
FIRST ADVANCE ONLINE PUBLICATION (ePUBLICATION AHEAD OF PRINT)
The Cardiovascular Journal of Africa has launched an Online First Advance Online Publication (ePublication ahead of print) with full text availability via Pubmed and this website which is accessible via Google and other search engines.

This facility is also known internationally as e-publication, ahead of print and offers authors the opportunity to publish their research articles sooner for an international audience. Read More »
dream cme 2013
ABOUT CVJA

Editorial Board
CVJA Info
Conference Calendar
Contact Us
JOURNAL ARTICLES

Current Issue
Online First Articles
Article Search
Journal Archive
Older Journal Archive
For the Patient
SERVICES

Log onto Sabinet
Submit Manuscript
Article Search
Subscribe to Journal (RSA)
Subscribe to Journal (Other)
Register for Editors’ Choice
Copyright Clearance
Why Should I Publish?
Register for Content Alerts
INFORMATION

Instructions for Authors
Submit Manuscript
Advertising Rates Card
Reviewers Information
MEDIA RESOURCES

Read Journal Online
Article Search
Chronic Heart Failure Guide
Video Archive
Follow us on Twitter
All Rights Reserved 2014 © Clinics Cardive Publishing (Pty) Ltd.
The content on this website is intended for healthcare professionals unless stated otherwise.

Advertisements on this website do not constitute a guarantee or endorsement by the journal or publisher of the quality or value
of such products or of the claims made for it by its manufacturer.

Website Development by Design Connection.